🇪🇺 Velcade in European Union

EMA authorised Velcade on 14 November 2019

Marketing authorisations

EMA — authorised 14 November 2019

  • Marketing authorisation holder: FRESENIUS KABI DEUTSCHLAND GMBH
  • Local brand name: Velcade
  • Status: approved

EMA

  • Application: EMEA/H/C/004207
  • Local brand name: Bortezomib Hospira
  • Status: withdrawn

Velcade in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Velcade approved in European Union?

Yes. EMA authorised it on 14 November 2019; EMA has authorised it.

Who is the marketing authorisation holder for Velcade in European Union?

FRESENIUS KABI DEUTSCHLAND GMBH holds the EU marketing authorisation.